Dr. Hamilton received her undergraduate degree from Washington and Lee University in Virginia and received a NCAA Postgraduate Scholarship.  She then completed her medical degree and residency from University of North Carolina in Chapel Hill and fellowship training in oncology at Duke University. She joined Sarah Cannon Research Institute as investigator in drug development for women’s cancers in 2013. Since 2015 she has served as the Director of the Breast Cancer Research Program.  She sees patients facing breast cancer from standard of care to phase II/III to phase I drug development. 

Dr. Hamilton was named to the Women to Watch Class of 2021 for Nashville Medical News. She was selected for ASCO’s Leadership Development Class for 2021-2022, the past Chair of ASCO’s Scientific Committee for Metastatic Breast Cancer for 2019-2020, and currently serves on ASCO’s Cancer Research Committee, and is the 2025 ASCO Annual Meeting Scientific Chair.  She was also elected to ASCO’s Nomination Committee in an undesignated slot for 2025-2028.  She is the 2023-2025 Scientific Committee Co-Chair of the ESMO Breast Cancer Meeting and is on the Scientific Committee for AACR. She serves an Associate Editor for Clinical Breast Cancer.